Illumina, Inc. (Illumina) is engaged in production development of sequencing-and array-based solutions for genetic analysis. It offers integrated systems, consumables and analysis tools for genetic analysis. Illumina also manufactures sequencing and array platforms, reagent kits and scanning equipment. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic and consumer genomics companies. Illumina's sequencing instruments perform a range of nucleic-acid analyses across a range of sample sizes. The Company's products and services are used for basic analysis and research, including de novo sequencing, genetic variation analysis, epigenetics and targeted screening, among others. It also provides products and services for other life sciences applied markets, such as agrigenomics.